- Home
- RRC vs RGC Comparison
RRC vs RGC Comparison
Compare RRC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRC | RGC |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.5B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RRC | RGC |
|---|---|---|
| Price | $38.97 | $5.72 |
| Analyst Decision | Hold | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $43.67 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 536.5K |
| Earning Date | 04-21-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 151.38 | N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | ★ $3,115,515,000.00 | N/A |
| Revenue This Year | $15.60 | N/A |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | $17.17 | ★ N/A |
| Revenue Growth | ★ 28.90 | N/A |
| 52 Week Low | $32.60 | $4.51 |
| 52 Week High | $48.31 | $69.00 |
Technical Indicators
Market Signals| Indicator | RRC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 32.41 |
| Support Level | $38.83 | $4.51 |
| Resistance Level | $40.69 | $29.26 |
| Average True Range (ATR) | 0.95 | 0.79 |
| MACD | 0.42 | 0.66 |
| Stochastic Oscillator | 82.57 | 36.12 |
Price Performance
Historical ComparisonAbout RRC Range Resources Corporation
Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.